MedPath

A Randomized Trial of Adjuvant Chemotherapy with UFT / LV versus PSK / UFT / LV following curative resection for Stage II / III Colorectal Cancer

Phase 2
Conditions
colorectal cancer
Registration Number
JPRN-UMIN000005484
Lead Sponsor
Gunma University Graduate School of Medicine Department of Thoracic and Visceral Organ Surgery
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
All
Target Recruitment
200
Inclusion Criteria

Not provided

Exclusion Criteria

1.Synchronous or metachronous colorectal cancer. 2.Severe infectious disease. 3.Severe postoperative complications. 4.Patients with following complications. 1)Uncontrolled diabetes or hyperpiesia. 2)Myocardial infarction within the past 6 months or unstable angina pectoris. 3)Hepatic cirrhosis , interstitial pneumonia , lung fibrosis, advanced pneumonectasia 5.Patients with diarrhea more than 3 times/day. 6.Active synchronous or metachronous malignancy carcinoma in situ. 7.Female who are pregnant, nursing, suspected of being pregnant or hope to become pregnant during the study period 8.Not suitable for participating in the study for any other reason.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
3 year desease free survival rate
Secondary Outcome Measures
NameTimeMethod
Survival time Adverse event rate Completion rate
© Copyright 2025. All Rights Reserved by MedPath